- Email: [email protected]
Smallpox eradication after 30 years: Lessons, legacies, and innovations
Vaccine 29 (2011) D6
Contents lists available at SciVerse ScienceDirect
Vaccine j o u r n a l h o m e p a g e : w w w. e l s e v i e r. c o m / l o c a t e / v a c c i n e
Symposium Acknowledgements
Acknowledgments: Smallpox Eradication after 30 Years: Lessons, Legacies, and Innovations We are very grateful to the many persons and organizations supporting the activities and the symposium “Smallpox Eradication after 30 Years: Lessons, Legacies and Innovations” and to those contributing to all Smallpox Eradication Commemoration 2010 (SEC2010) activities. The symposium could not have been possible without the Sabin Vaccine Institute, serving both as secretariat for the symposium and this publication, and the Fogarty International Center (FIC) of the U.S. National Institutes of Health (NIH) and the Oswaldo Cruz Foundation (FIOCRUZ), Brazil for administrative support. We are grateful to the following for their generous financial and in-kind support to the symposium: Bill & Melinda Gates Foundation; Global Health Institute at Emory University; FIC of the NIH; National Institute of Allergy and Infectious Diseases (NIAID) of the NIH; Oswaldo Cruz Foundation (FIOCRUZ), Brazil; The Rockefeller Foundation; Sabin Vaccine Institute; The United Nations Foundation; Wellcome Trust; and, Wellcome Trust Centre for the History of Medicine at University College London. We also thank: the Pan American Health Organization (PAHO); Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ); Ministry of Health, Brazil; and, the World Health Organization. We note with thanks the contributions of Nadrian Teclar and Mantra Singh at the FIC, NIH; and, Gilberto Hochman, Bia Ayres and Deolinda Santos at FIOCRUZ for their key roles in making the symposium a success. We also thank Rodrigo Correa, Don Francis and Joe Esposito for organizing the poster session. We especially thank Brian C. Shaw, Program Officer at the Sabin Vaccine Institute, for coordinating and managing the symposium and serving as Managing Editor of this publication. The guidance of Vaccine editorial staff, especially Greg Poland (editor), Thomas (Hank) Miller, and John Bailey is appreciated. Finally, we would like to thank all of those who took time out of their busy schedules to review the manuscripts submitted for this supplement. Without their careful review and insightful comments this publication would not have been possible.
0264-410X/$ – see front matter doi:10.1016/j.vaccine.2011.11.038
Contents lists available at SciVerse ScienceDirect
Vaccine j o u r n a l h o m e p a g e : w w w. e l s e v i e r. c o m / l o c a t e / v a c c i n e
Symposium Acknowledgements
Acknowledgments: Smallpox Eradication after 30 Years: Lessons, Legacies, and Innovations We are very grateful to the many persons and organizations supporting the activities and the symposium “Smallpox Eradication after 30 Years: Lessons, Legacies and Innovations” and to those contributing to all Smallpox Eradication Commemoration 2010 (SEC2010) activities. The symposium could not have been possible without the Sabin Vaccine Institute, serving both as secretariat for the symposium and this publication, and the Fogarty International Center (FIC) of the U.S. National Institutes of Health (NIH) and the Oswaldo Cruz Foundation (FIOCRUZ), Brazil for administrative support. We are grateful to the following for their generous financial and in-kind support to the symposium: Bill & Melinda Gates Foundation; Global Health Institute at Emory University; FIC of the NIH; National Institute of Allergy and Infectious Diseases (NIAID) of the NIH; Oswaldo Cruz Foundation (FIOCRUZ), Brazil; The Rockefeller Foundation; Sabin Vaccine Institute; The United Nations Foundation; Wellcome Trust; and, Wellcome Trust Centre for the History of Medicine at University College London. We also thank: the Pan American Health Organization (PAHO); Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ); Ministry of Health, Brazil; and, the World Health Organization. We note with thanks the contributions of Nadrian Teclar and Mantra Singh at the FIC, NIH; and, Gilberto Hochman, Bia Ayres and Deolinda Santos at FIOCRUZ for their key roles in making the symposium a success. We also thank Rodrigo Correa, Don Francis and Joe Esposito for organizing the poster session. We especially thank Brian C. Shaw, Program Officer at the Sabin Vaccine Institute, for coordinating and managing the symposium and serving as Managing Editor of this publication. The guidance of Vaccine editorial staff, especially Greg Poland (editor), Thomas (Hank) Miller, and John Bailey is appreciated. Finally, we would like to thank all of those who took time out of their busy schedules to review the manuscripts submitted for this supplement. Without their careful review and insightful comments this publication would not have been possible.
0264-410X/$ – see front matter doi:10.1016/j.vaccine.2011.11.038